Human prion strain selection in transgenic mice

Annals of Neurology

Volumn 68, Issue 2, 2010, Pages 151-161

  Giles, Kurt ^a,b   Glidden, David V ^b   Patel, Smita ^a   Korth, Carsten ^a   Groth, Darlene ^a   Lemus, Azucena ^b   DeArmond, Stephen J ^a,b   Prusiner, Stanley B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PRION PROTEIN; PRION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CREUTZFELDT JAKOB DISEASE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; HUMAN; HUMAN TISSUE; INCUBATION TIME; INOCULATION; MOUSE; MOUSE STRAIN; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; CELL FRACTIONATION; DISEASE MODEL; GENETIC VARIABILITY; GENETICS; METABOLISM; PRION;

ANIMALS; CREUTZFELDT-JAKOB SYNDROME; DISEASE MODELS, ANIMAL; GENETIC VARIATION; HUMANS; MICE; MICE, TRANSGENIC; PRIONS; PRPSC PROTEINS; SUBCELLULAR FRACTIONS;

EID: 77955298267     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22104     Document Type: Article

References (59)

1. Prusiner SB. Shattuck lecture - neurodegenerative diseases and prions. N Engl J Med 2001;344:1516-1526.
2. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-925.
3. Lasmézas CI, Deslys J-P, Demaimay R, et al. BSE transmission to macaques. Nature 1996;381:743-744.
4. Collinge J, Sidle KCL, Meads J, et al. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996;383:685-690.
5. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 1997;389:498-501.
6. Scott MR, Safar J, Telling G, et al. Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc Natl Acad Sci U S A 1997;94:14279-14284. (Pubitemid 28041364)
7. Scott MR, Will R, Ironside J, et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A 1999;96:15137-15142. (Pubitemid 30019778)
8. Scott MR, Peretz D, Nguyen H-OB, et al. Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol 2005;79:5259-5271. (Pubitemid 40548194)
9. Pattison IH, Millson GC. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 1961;71:101-108.
10. Dickinson AG, Mackay JMK, Zlotnik I. Transmission by contact of scrapie in mice. J Comp Pathol 1964;74:250-254.
11. Dickinson AG, Fraser H. An assessment of the genetics of scrapie in sheep and mice. In: Prusiner SB, Hadlow WJ, eds. Slow transmissible diseases of the nervous system. Vol 1. New York, NY: Academic Press, 1979:367-386.
12. Bruce ME, Dickinson AG, Fraser H. Cerebral amyloidosis in scrapie in the mouse: effect of agent strain and mouse genotype. Neuropathol Appl Neurobiol 1976;2:471-478.
13. Bruce ME, Dickinson AG. Genetic control of amyloid plaque production and incubation period in scrapie-infected mice. J Neuropathol Exp Neurol 1985;44:285-294.
14. Bruce ME, Dickinson AG. Biological stability of different classes of scrapie agent. In: Prusiner SB, Hadlow WJ, eds. Slow transmissible diseases of the nervous system. Vol 2. New York, NY: Academic Press, 1979:71-86.
15. Ridley RM, Baker HF. To what extent is strain variation evidence for an independent genome in the agent of the transmissible spongiform encephalopathies? Neurodegeneration 1996;5:219-231.
16. Bruce ME, Dickinson AG. Biological evidence that the scrapie agent has an independent genome. J Gen Virol 1987;68:79-89.
17. Meyer N, Rosenbaum V, Schmidt B, et al. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. J Gen Virol 1991;72:37-49.
18. Safar JG, Kellings K, Serban A, et al. Search for a prion-specific nucleic acid. J Virol 2005;79:10796-10806.
19. Bessen RA, Marsh RF. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 1992;66:2096-2101.
20. Telling GC, Parchi P, DeArmond SJ, et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996;274:2079-2082.
21. Legname G, Nguyen H-OB, Peretz D, et al. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A 2006;103:19105-19110.
22. Toyama BH, Kelly MJ, Gross JD, Weissman JS. The structural basis of yeast prion strain variants. Nature 2007;449:233-237.
23. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007;318:930-936. (Pubitemid 350098981)
24. Colby DW, Giles K, Legname G, et al. Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A 2009;106:20417-20422.
25. Colby DW, Wain R, Baskakov IV, et al. Protease-sensitive synthetic prions. PLoS Pathog 2010;6:e1000736.
26. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-778. (Pubitemid 26183813)
27. Hill AF, Collinge J. Subclinical prion infection in humans and animals. Br Med Bull 2003;66:161-170. (Pubitemid 37173500)
28. Uro-Coste E, Cassard H, Simon S, et al. Beyond PrPres type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 2008;4:e1000029.
29. Levavasseur E, Laffont-Proust I, Morain E, et al. Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease - implications for the dissemination and the diagnosis of human prion strains. PLoS One 2008;3:e2786.
30. Parchi P, Strammiello R, Notari S, et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. Acta Neuropathol 2009;118:659-671.
31. Cali I, Castellani R, Alshekhlee A, et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 2009;132:2643-2658.
32. Telling GC, Scott M, Hsiao KK, et al. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A 1994;91:9936-9940.
33. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995;83:79-90.
34. Korth C, Kaneko K, Groth D, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse - human prion protein transgene. Proc Natl Acad Sci U S A 2003;100:4784-4789. (Pubitemid 36457806)
35. Bartz JC, Bessen RA, McKenzie D, et al. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol 2000;74:5542-5547.
36. Li J, Browning S, Mahal SP, et al. Darwinian evolution of prions in cell culture. Science 2010;327:869-872.
37. Ghaemmaghami S, Ahn M, Lessard P, et al. Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog 2009;5:e1000673.
38. Scott M, Foster D, Mirenda C, et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 1989;59:847-857. (Pubitemid 20022375)
39. Scott MR, Köhler R, Foster D, Prusiner SB. Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci 1992;1:986-997. (Pubitemid 23009207)
40. Giles K, Glidden DV, Beckwith R, et al. Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation. PLoS Pathog 2008;4:e1000206.
41. Carlson GA, Kingsbury DT, Goodman PA, et al. Linkage of prion protein and scrapie incubation time genes. Cell 1986;46:503-511.
42. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
43. Brookmeyer R, Crowley J. A confidence interval for the median survival time. Biometrics 1982;38:29-41.
44. Muramoto T, DeArmond SJ, Scott M, et al. Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an a-helix. Nat Med 1997;3:750-755. (Pubitemid 27298718)
45. Peretz D, Supattapone S, Giles K, et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 2006;80:322-331.
46. Prusiner SB. Molecular biology of prion diseases. Science 1991;252:1515-1522.
47. Tanaka M, Chien P, Naber N, et al. Conformational variations in an infectious protein determine prion strain differences. Nature 2004;428:323-328. (Pubitemid 38418803)
48. Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006;442:585-589. (Pubitemid 44167919)
49. Wilesmith JW, Ryan JBM, Atkinson MJ. Bovine spongiform encephalopathy: epidemiologic studies on the origin. Vet Rec 1991;128:199-203.
50. Pattison IH. Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. In: Gajdusek DC, Gibbs CJ Jr, Alpers MP, eds. Slow, latent and temperate virus infections. NINDB Monograph 2. Washington, DC: US Government Printing Office, 1965:249-257.
51. Asante EA, Linehan JM, Desbruslais M, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002;21:6358-6366. (Pubitemid 35448414)
52. Kimberlin RH, Walker CA. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 1978;39:487-496.
53. Dickinson AG, Fraser H, Meikle VMH, Outram GW. Competition between different scrapie agents in mice. Nat New Biol 1972;237:244-245.
54. Schutt CR, Bartz JC. Prion interference with multiple prion isolates. Prion 2008;2:61-63.
55. Shikiya RA, Ayers JI, Schutt CR, et al. Co-infecting prion strains compete for a limiting cellular resource. J Virol 2010;84:5706-5714.
56. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-421. (Pubitemid 38210057)
57. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-529.
58. Health Protection Agency. Variant CJD and plasma products. 2009. Available at: http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb-C/ 1195733818681?p=1225960597236. Accessed July 12, 2010.
59. Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004;203:733-739. (Pubitemid 38961558)